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ABSTRACT 
Objective: Each of Borrelia burgdorferi sensu stricto, Borrelia 
garinii, and Borrelia akelii has characteristic restriction sites in 
its flagellin gene. The authors focused on this gene and devel- 
oped a polymerase chain reaction-restriction fragment length 
polymorphism (PCR-RFLP) analysis for rapid diagnosis of Lyme 
disease. 
Methods: External and internal primer sets were designed for 
nested PCR to amplify an approximately 580 bp fragment of 
the flagellin gene that includes species-specific restriction sites. 
DNA extracted from tissue samples of mice and humans were 
used as templates for PCR. The amplicons obtained were 
digested with Hapll, Hhal, Celll, Hincll, or Ddel endonuclease. 
Results: In mice experimentally infected with each of B. 
burgdotferi sensu stricto, B. garinii, and B. afzelii, borrelial DNA 
was detected irrespective of differences in the causative 
species. However, RFLP of the amplicons was able to identify 
the species. Skin biopsy samples from 11 Japanese patients 
with erythema migrans were subjected to both PCR and cul- 
ture tests. Borrelial infections were detected in seven cases 
(64%) by PCR and eight cases (73%) by culture. All PCR-pos- 
itive samples were also positive by culture. The causative 
species in human infections was easily identified as B. garinii 
by RFLP analysis of the amplicons. 
Conclusion: The nested PCR-RFLP system appears to be an 
easy and reliable diagnostic tool for the detection and species 
identification of borreliae in human cutaneous biopsies. 
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Lyme disease caused by Borrelia burgdorferi sensu 
stricto, Borrelia garinii, or Borrelia afzelii is the most 
common tick-borne illness in North America and Eura- 
sia.lz2 Although all three species prevail in Europe, only B. 
burgdorferi sensu strict0 is found in North America. In the 
Far East, both B. garinii and B. afzelii are found.3-5 The 
organisms are transmitted to humans by bites of infected 
ticks of the &odes ricinus species complex. Infection in 
humans leads to a variety of manifestations, including der- 
matopathy, cardiopathy, neuropathy, and arthropathy6 Epi- 
demiologic and clinical data in Europe suggest that each 
of the Lyme disease pathogens has a characteristic path- 
ogenic potential. 1,2,7,8 Infection with B. burgdorferi sensu 
stricto seems to cause arthritis, whereas neurologic symp- 
toms are associated with B. garinii. The late cutaneous 
symptom of acrodermatitis chronica atrophicans appears 
to be related to B. afzelii. The early cutaneous manifesta- 
tion of erythema migrans around the sites of tick bites 
frequently occur irrespective of differences in the causative 
species. Although erythema migrans and acrodermatitis 
chronica atrophicans are characteristic for Lyme disease, 
many symptoms involving internal organs are less char- 
acteristic. Therefore, confirmation of the clinical diagno- 
sis is attempted mostly by measuring antibodies against 
borreliae. However, the diagnostic value of serologic tests 
is substandard because of low sensitivity and cross-reac- 
tivity.9x’o The results of serologic tests may also be con- 
fused by the polymorphism of immunogenic outer surface 
proteins.“-‘* 
Recent phylogenetic studies demonstrated several tax- 
ons related to the Lyme disease borreliae.15-l8 At present, 
Borrelia andersonii and group DN127 in North Amer- 
ica 17,18 groups PotiB2 and WI16 in Europe,i8 and Borre- 
lia’japonica, Borrelia tanukii, and Borrelia turdae in 
Japan19,20 are recognized and have been isolated from ixo- 
did ticks which are able to feed on humans. Moreover, 
Borrelia miyamotoi in Japan and Borrelia lonestari in 
North America, which are related to relapsing fever bor- 
reliae, have been found in ixodid ticks.21,22 The patho- 
genicity of these different taxons is unresolved, and 
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reliable methods for identifying the pathogens from clin- 
ical samples are needed for diagnostic laboratories. Pre- 
vious phylogenetic analysis of Borrelia species revealed 
that their flagellin genes have a marked utility in taxon- 
omy. I6 Based on the alignment data of the flagellin gene 
sequences of various Borrelia species, the authors devel- 
oped a polymerase chain reaction-restriction fragment 
length polymorphism (PCR-RFLP) analysis for distin- 
guishing the Lyme disease borreliae from other related 
taxons.16 In the current study, this technique was applied 
to clinical diagnosis of Lyme disease and evaluated its 
diagnostic value in comparison with the ordinary culture 
methods for isolating borreliae. For detecting borrelial 
DNA from tissue samples, the sensitivity of PCR was 
increased by using a nested method, using external and 
internal primer sets. The PCR analysis was first performed 
in tissue samples from mice experimentally infected with 
B. burgdorferi sensu stricto, B. garinii, or B. afzelii and 
then applied to cutaneous biopsy samples from erythe- 
matous lesions of tick-bite victims in Japan. 
MATERIAL AND METHODS 
Mice 
Female BALB/c mice (7- or B-weeks-old), which were bred 
in the Animal Laboratory for Medical Research, Asahikawa 
Medical College, were used for all experiments. The mice 
were infected with borreliae by intraperitoneal inocula- 
tion of approximately 10’ cultured cells or by bites of 
infected nymphal ticks of Ixodes persulcatus. 
Borreliae 
Low-passaged strains 297 and NCH-1 of B. burgdorferi 
sensu strict0 were used for infecting mice. These were 
kindly provided by T. Masuzawa, University of Shizuoka, 
Japan. Other low-passaged strains used were B. garinii 
N346 and B. afielii N391. These were the original isolates 
from I. persulcatus in Hokkaido, Japan. Borrelia garinii 
JEM6 isolated from an erythema lesion of a patient with 
Lyme disease in Hokkaido were also used.z3 According 
to the system defined by Piesman,‘* this strain has been 
maintained by alternate passage between I. persulcatus 
ticks and Mongolian jirds (Meriones unguiculatus). The 
JEMG-infected nymphs were reared from replete larvae 
that had fed on infected jirds. Infection of mice with the 
JEM6 strain was induced by exposure of 12 infected 
nymphs. The infection rate of nymphs used was approx- 
imately 100% as determined by direct-fluorescent anti- 
body technique.25 
Culture 
A BSK II medium containing rifampin (50 kg/mL) was 
used for isolating borreliae.26 Minced tissue samples 
(approximately 10 mg) were individually inoculated into 
6 mL of medium in a culture tube. The tubes were incu- 
bated at 31°C and were examined for borreliae by dark- 
field microscopy biweekly for 4 weeks. In cutaneous 
samples from mice and humans, the skin surface was wet- 
ted with 10% povidone-iodine solution and cleaned with 
70% ethanol before samples were taken. 
Template DNA 
A spin column kit (QIAamp Tissue Kit; QIAGEN Inc., 
Chatsworth, CA) was used for rapid purification of DNA 
from tissue samples. Using the attached buffer system, DNA 
was extracted as recommended by the manufacturer. In 
brief, approximately 10 mg of tissue (3 to 4 mm3) was 
incubated in lysis buffer at 55°C for 3 hours, and then DNA 
was absorbed in a spin column. After the spin column was 
washed, DNA was eluted with 400 ~J,L elution buffer. The 
eluted DNA solution was directly used as a template for 
nested PCR. The concentration of DNA was determined 
spectrophotometricaIly by measuring the %6,, (range, 30 to 
60 pg/rnL in murine samples; 15 to 30 pg/rnL in human 
samples). 
Nested Polymerase Chain Reaction 
Oligonucleotide primers were prepared by a custom syn- 
thesis service (Funakoshi Co. Ltd., Tokyo, Japan). The 
external primer set used was as follows: 5’-TCT GAT GAT 
GCT GCT GGT ATG G-3’ (sense primer A) and 5’-CTG 
CTA CAA CCT CAT CTG TCA T-3’ (antisense primer B). 
The previously published set was used as an internal 
primer set: 5’-GCA GTT CAA TCA GGT AAC GG-3’ (sense 
primer C) and 5’-AGG TTT TCA ATA GCA TAC TC-3’ 
(antisense primer D).i6 Those primers were designed 
from the flagellin gene sequence of B. garinii HT22.’ 
Primers A and B are located at the nucleotide positions 
118 to 139 and 898 to 919, respectively Primers C and 
D are located at 280 to 299 and 844 to 863, respectively. 
Those positions are correspondent to the conserved 
region of the flagellin genes of Lyme disease borreliae 
and their relative species. All primers were Bowelia-spe- 
cific, as confirmed by using the basic local alignment 
search tool (BLAST) algorithm and the GenBank database. 
The first PCR was carried out in a 25 PL (total volume) 
reaction mixture containing 2.5 ~.LL template DNA, each 
deoxynucleotide triphosphate at a concentration of 200 
PM, each external primer at a concentration of 0.1 ~J,M, 
1U of Taq polymerase (Ex Taq; Takara Co. Ltd., Kyoto, 
Japan), and Ex Tag reaction buffer. The reaction mixtures 
were overlaid with mineral oil and were subjected to 30 
thermal cycles consisting of 94°C for 40 seconds, 63°C 
for 60 seconds, and 72” for 60 seconds. After amplica- 
tions, 2.5 FL of the first PCR was transferred to a second 
PCR consisting of the same reaction mixture, but instead 
of external primers each internal primer at a concentra- 
tion of 0.5 FM was added. The second PCR was run 
through 30 cycles of 94°C for 40 seconds, 50°C for 40 sec- 
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onds, and 72°C for 40 seconds. To examine the amplified 
product, a 5 FL aliquot of the reaction mixture was elec- 
trophoresed in 2.5% agarose gel (NuSieve GTG; FMC Bio- 
Products, Rockland, ME) with TBE buffer (100 n&I Tris; 
90 mM boric acid; 1 mM EDTA, pH 8.3). Amplified frag- 
ments were visualized by ethidium bromide staining. DNA 
ladders, 100 bp ladder (100-1000 bp) and 20 bp ladder 
(20-1000 bp) (GenSura Laboratories, Del Mar, CA), were 
used as size markers. 
A panel of positive and negative controls was 
included in each nested PCR analysis to monitor conta- 
mination and false negative amplification. Template DNA 
extracted from earlobe tissues of mice infected with L?. 
burgdorferi sensu strict0 297 was used as a positive con- 
trol and template DNA from earlobes of normal mice was 
used as a negative control. 
Restriction Fragment Length Polymorphism 
As shown in Figure 1, the expected PCR product was an 
approximately 580 bp fragment, including species-spe- 
cific restriction sites. The amplicons obtained were 
digested with HapII, HhaI, H&c11 (Takara), CeGII (Phar- 
macia, Uppsala, Sweden), or DdeI (TOYOBO, Osaka, Japan) 
as recommended by suppliers. The endonuclease digests 
were electrophoresed and resultant RFLP patterns were 
classified into flagellin (fla) types as previously reported. l6 
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Figure 1. Schematic diagram of locations of PCR primer sets on 
the flagellin gene and restriction maps of amplified fragment. Open 
arrowheads indicate the external primers A and B for the first PCR. 
Closed arrowheads indicate the internal primers C and D for the sec- 
ond PCR. The flagellin (fla) types are given in parentheses. Lengths of 
cleaved fragments (in bp) discernible in 2.5% agarose gels are shown 
in the restriction maps. The maps are based on the sequences of the 
type strains (accession nos. of the GenBankIEMBUDDBJ databases): 
B31 (X16933), 20047 (D82846), and VS461 (D63365). 
The fla types I, II, and III correspond to B. burgdorferi 
sensu stricto, B. garinii, and B. afzelii, respectively. 
Because the PCR-RFLP patterns of B, garinii were het- 
erogeneous, the fla type II was divided into seven sub- 
types (designated subtypes IIa to IIg). 
Clinical Samples 
In cooperation with many dermatologists, human cuta- 
neous biopsy samples were collected from tick-bite vic- 
tims in Hokkaido and Nagano, Japan, where Lyme disease 
is endemic, during May to August in 1996. Based on the 
surveillance criterion of Centers for Disease Control and 
Prevention, a rash of 5 cm or larger was defined as ery- 
thema migrans. 27 Biopsy samples were taken from the 
peripheral reddish area of erythema. In some typical cases 
of erythema migrans, biopsy samples were taken from 
peripheral reddish and central non-reddish areas. Under 
sterile and cool conditions, the samples were transported 
to the laboratory within 1 to 2 days. The sample was 
divided in half and one piece was inoculated into BSK II 
medium; the remaining piece was preserved at -70°C 
until use for DNA preparation. 
Confirmation of Species Identification 
In human samples, the species status directly deter- 
mined by nested PCR-RFLP analysis was verified by clas- 
sifying the clinical isolates into ribotypes. The 
experimental conditions of ribotyping have been 
described.4 The fla types also were determined in the 
clinical isolates, by previously published non-nested 
PCR-RFLP analysis.” 
RESULTS 
Sensitivity of Polymerase Chain Reaction 
The sensitivity of the nested PCR system was evaluated 
(Table 1). Accurately prepared IO-mg earlobe pieces of 
normal mice and serial dilutions of cultured cells of B. 
afzelii N391 were used. For preparing template DNA, 
Table 1. Sensitivity of Nested Polymerase Chain Reaction for 
Detection of Borrelial Flagellin Gene 
Duplicate PCR 
Number of Borrelia Cells 
Added to 10 mg Sample* First Second 
104 (+M+) 4-k 
103 -- / +/+ 
10' -/- 4-t 
10 -/- +I- 
1 -/- -- 
0 -- / -- : 
*The cells of B. &e/ii N391 were added to normal murine earlobes for 
preparing template DNA. 
+ = positive; (+) = weakly positive; - = negative. 
Nested PCR for Diagnosis of Lyme Disease / Suto et al 67 
Table 2. Detection of Borrelial Infections in Mice by Nested Polymerase Chain Reaction and Culture 
Positive (%I 
Borrelia Strains Number of Mice* 
PCR Culture 
Earlobe Heart Earlobe Heart 
Results of 
RFLP Typing+ 
6. burgdorferi NCH-1 4 4 (100) 4 (100) 4 (100) 4 (100) fla I 
B. burgdotferi 297 5 5 (100) 5 (100) 5 (100) 5 (100) fla I 
B. garinii N346 4 4 (100) 4 (100) 3 (75) 3 (75) fla Ila 
B. garinii JEM6 71 7 (I 00) 7 (100) 5 (71) 7 (100) fla Ile 
B. afze/ii N391 6 6 (100) 6 (100) 6 (100) 4 (67) fla Ill 
Uninfected 3 0 (0) 0 (0) 0 (0) 0 (0) 
*All mice were killed 3-5 weeks after infection for sampling earlobes and hearts. tAll of the resultant PCR amplicons were examined by restriction fragment length 
polymorphism analysis. *Mice were infected by bites of nymphal ticks. 
fla = flagellin. 
each piece was lysed together with 1, 10, lo*, 103, or lo* positive signals were obtained in samples mixed with 1 
borrelial cells. Using those templates, the experiment of to lo3 cells; however, a weak positive signal of 800 bp was 
amplification was done in duplicate. In the first PCR, no detected in a sample mixed with lo* cells. In the second 
Bbl (f/a I) Bgl (f/a Ila) Bal (f/a III) 
2 t!! =-(v=-= =- 
Figure 2. Nested PCR-RFLP analysis in mice 
infected with Lyme disease borreliae. A, Signal detec- 
tion by the first and second PCR. Template DNA was 
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PCR, a strong positive signal of 580 bp was constantly 
detected in samples mixed with 10’ to lo* cells. In a sam- 
ple mixed with 10 cells, one of the duplicated reactions 
was negative. Based on this result, the density of 10 to lo2 
cells per 10 mg cutaneous tissue was estimated to be the 
lower limit for detecting infections. 
Amplification of Borrelial DNA in Infected Mice 
Earlobe and heart tissues of mice experimentally infected 
with B. burgdorferi sensu stricto, B. garinii, or B. afzelii 
were used to determine whether the PCR system was 
able to detect borrelial infections irrespective of differ- 
ences in the causative species. The sensitivities for detect- 
ing infections between PCR and culture tests also were 
compared. All tissue samples used were taken from mice 
3 to 5 weeks after infection. As summarized in Table 2, 
PCR showed positive results in all tissue samples from 
mice infected with each borrelial strain (B. burgdorferi 
sensu strict0 NCH-1 and 297, B. garinii N346, and B. 
afzelii N391) by needle inoculation of cultured cells. 
Even in mice naturally infected with B. garinii JEM6 by 
tick bites, positive PCR signals were obtained in all tissue 
samples. Although the first PCR was ineffective in detect- 
ing signals, an approximately 580 bp fragment was ampli- 
fied by the second PCR in all tissue samples of infected 
mice (Figure 2, A). The RFLPs of all amplicons obtained 
from the tissue samples were examined. The fla types 
directly determined in each tissue sample were com- 
pletely consistent with those of BorreZia species infected 
in mice (see Table 2; Figure 2, B). The culture test was also 
excellent for detecting infections; however, its sensitivity 
was slightly lower than that of PCR. 
Negative Conversion of Polymerase Chain Reaction 
Signals in Mice after Antibiotic Treatment 
Mice naturally infected with B. garinii JEM6 by bites of 
infected nymphs, were used to determine whether the 
positive results of PCR were converted to negatives after 
antibiotic treatment. Twelve infected mice were used for 
this experiment. Of those, six mice were treated with 
intraperitoneal injection of ceftriaxone (Rocephin; Japan 
Roche Inc., Tokyo, Japan). The other six untreated mice 
served as positive controls. The antibiotic treatment started 
at 21 days after tick exposure. After taking biopsy sam- 
ples from earlobes, the antibiotic (10 mg/d) was injected 
into each mouse for 5 consecutive days. The treated mice 
were killed at two different intervals (6 days and 41 days 
after treatment) for sampling earlobe and heart tissues. 
Necropsy samples were similarly collected from untreated 
mice. All biopsy and necropsy samples were subjected to 
both PCR and culture tests. As summarized in Table 3, 
negative conversion of PCR signals was observed in all 
treated mice. The negative result of culture tests in treated 
mice also indicated that borreliae were eliminated from 
murine tissues after antibiotic treatment. 
Clinical Application of Polymerase Chain Reaction 
The diagnostic value of the nested PCR system was eval- 
uated by using human cutaneous biopsy samples taken 
from tick-bite victims in Japan. As shown in Table 4,26 
biopsy samples from 23 victims (designated patient 1 to 
23) were subjected to both PCR and culture tests. Of 
those victims, 12 cases showed small erythematous 
lesions that were considered to be hypersensitivity reac- 
tions induced by tick bites. The other 11 cases (patient 2, 
6,8,10,13,14,15,l6,20,22, and 23) were clinically diag- 
nosed as erythema migrans. Of those cases, the compli- 
cation of facial palsy arose in patient 2. The remaining 
cases showed uncharacteristic symptoms, such as fatigue 
and fever. Patient 10,13, and 22 showed typical erythema 
migrans characterized by an annular rash expanding cen- 
trifugally with central clearing. In those cases, we could 
examine two biopsy samples taken from peripheral red- 
dish and central non-reddish areas. 
Also in human samples, the first PCR was insensitive; 
however, an expected 580 bp fragment could be ampli- 
fied by the second PCR (Figure 3, A). In the samples of 
small erythematous lesions, both PCR and culture tests 
were negative; however, positive results were obtained 
in several samples of erythema migrans (see Table 4). In 
three cases with typical erythema migrans, all biopsy sam- 
ples from peripheral reddish and central non-reddish 
areas were positive for both tests. Of 11 cases of ery- 
thema migrans, borrelial infections were detected in seven 
Table 3. Negative Conversion of Nested Polymerase Chain Reaction Signals in Mice Infected with /3. garinii JEM6 after Antibiotic Therapy 
Detection of Borrelial Infections* 
Groups of Mice+ 
Biopsy Samples Necropsy Samples 
PCR Culture PCR Culture 
Earlobe Earlobe Earlobe Heart Earlobe Heart 
Treated (6 days) 3/3 3/3 013 O/3 O/3 O/3 
Untreated (6 days) 3/3 3/3 3/3 3/3 
Treated (41 days) 3/3 3/3 Q/3 O/3 O/3 o/3 
Untreated (41 days) 3/3 3/3 3/3 3/3 
*Number positive/number examined. iAntibiotic therapy started at 21 days after exposure to infected nymphal ticks. After taking biopsy samples from earlobes, mice 
were treated with ceftriaxone for 5 consecutive days. The treated and untreated mice were killed 6 days and 41 days after therapy. 
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Table 4. Clinical Application of Nested Polymerase Chain Reaction to 
Detect Borrelial DNA from Cutaneous Biopsy Samples of Tick-Bite Victims 
Test Results of Biopsy Samples Established isolates 
Patient Sex Age (Y) Clinical Diagnosis (Biopsy Site) PCR (f/a Type) Culture fla Type Ribotype 
1 F (62) Small  etythema (P) - - 
2 F (63) E M  and facial palsy (P) + (Ila) + Ila Ila 
3 F (79) Small  erythema (P) - - 
4 M  (47) Small  erythema (P) - - 
5 M  (20) Small  erythema (P) - . 
6 F (4) E M  (PI + (lla) + Ila IVa 
7 M  (36) Small  erythema (P) - - 
8 F (75) E M  P) - 
9 F (70) Small  erythema (P) - 
10 M  (57) E M  P) + (Ild) + Ild IVa 
CC) + (lla) + Ila IVa 
11 F 038) Small  etythema (P) - - 
12 M  (56) Small  erythema (P) - 
13 M  (69) E M  P) + (Ild) + Ild IVa 
(C) + (Ild) + Ild IVa 
14 F (59) E M  (PI + (Ha) + Ila IVa 
15 F (63) E M  F’) - + Ila Ila 
16 F (61) E M  F’) + (lie) + Ile IVa 
17 F (61) Small  eythema (P) - 
18 M  (55) Small  etythema (P) - 
19 F (60) Small  erythema (P) - 
20 M  (53) E M  P) - - 
21 F (18) Small  erythema (P) - - 
22 F (47) E M  P) + (Ila) + Ila IVa 
(C) + (lla) + Ila IVa 
23 F (55) E M  P) 
F = female; M  = male; E M  = etythema migrans; P  = peripheral pari of erythema (reddish area); C = central part of erythema migrans (non-reddish area), 
(64%) by PCR and in eight (73%) by culture. Fisher’s exact 
probability test revealed that these values did not differ 
significantly (P = 0.5). All PCR-positive samples were also 
positive by culture. Each RFLP pattern of PCR amplicons 
was classified into the fla type IIa, IId, or IIe (see Table 4 
and Figure 3, B). The results of fla typing of established 
isolates were completely consistent with the directly 
determined results in tissue samples. All of the fla types 
determined in human samples corresponded to B. gurinii. 
Species identification by ribotyping classified each estab- 
lished isolate into the ribotype Ila or IVa according to 
the typing scheme described previously.* All ribotypes 
determined in this study also corresponded to B. gurinii. 
DISCUSSION 
In northern Japan, the adult ticks of Lpersulcatus aggres- 
sively attack humans and serve as a vector for Lyme dis- 
ease. Several studies indicated that borreliae isolated from 
Ipersulcatus were highly heterogeneous in their outer 
surface proteins, OspA and OS~B.~~~~~ Since the serotyp- 
ing of Osp proteins seems to be insufficient for species 
identification, the ribotyping system for epidemiologic 
studies was developed.*,j The studies revealed that Japan- 
ese Lpersulcatus harbors borreliae belonging to the ribo- 
type II (B. garinii), III (B. afzeZii>, w y or VI. Although the 
latter three ribotypes are regarded as unknown species,* 
a recent phylogenetic study on the flagellin gene demon- 
strated that those are intraspecies variants of B. garinii.3 
Most patients with Lyme disease in Japan show only 
symptoms of fever, malaise, and erythema migrans after 
tick bites, and severe multisystemic manifestations, such 
as cardiopathy, neuropathy, and arthropathy, are uncom- 
mon in comparison with European and North American 
Lyme disease. 23 A possible reason for the clinical differ- 
ence relates to the specific B. garinii strains in Japan, 
although other factors, such as ethnic difference in 
patients cannot be ignored. 
The authors previously reported that, in Japan, bor- 
reliae were easily isolated by using erythema migrans 
lesions of tick-bite victims as culture sources and most of 
the isolates were classified as B. garinii.3~4J3 Confirma- 
tion of causative species seems to be unnecessary for 
diagnostic laboratories; however, differential diagnosis is 
still required because several Borrelia species whose 
pathogenicities are unknown are also distributed in 
Japan.19,20 In vitro cultivation is the most reliable method 
for the direct demonstration of borreliae from human 
cutaneous tissues, although cultivation is time-consum- 
ing and the results vary among laboratories.29,30 Species 
identification of borrelial isolates from clinical samples 
has been carried out mainly by Western blot (serotyp- 
ing) or Southern blot (ribotyping) analysis.1,2,4,12,14 How- 
ever, both methods are also time-consuming. These 
70 International Journal of Infectious Diseases / Volume 2, Number 2, October-December 1997 
The First PCR il! The Second PCR 
Figure 3. Clinical application of nested PCR-RFLP analysis for human cutaneous biopsy 
samples. A, Signal detection by the first and second PCR. Template DNA was prepared from 
erythematous lesions of tick-bite victims. Markers, 100 bp ladder (100-l 000 bp); P2, P3, 
P6, P9, PI 1, P13, Pi 6, and PI 8, samples from patients summarized in Table 4. P2, P6, 
P13, and PI6 were clinically diagnosed as erythema migrans. The second PCR yielded 
products of 580 bp in length for samples of P2, P6, P13, and P16. B, RFLP of amplicons 
derived from samples of P2, P13, and P16. Lengths of DNA fragments (in bp) are as fol- 
lows: P2 (Hapll, 580; Hhal, 400 and 180; Celll, 580; Hincll, 450 and 130; Ddel, 330, 150, 
and 70), PI3 (Hapll, 320 and 260; Hhal, 400 and 180; Celll, 580; Hincll, 450 and 130; Ddel, 
330, 150, and 70) and P16 (HaoIl, 370 and 210; Hhal, 400 and 180; Celll, 580; Hincll, 450 
and 130; Ddel, 330, 150, and 70). The flagellin (fla) types are indicated in parentheses. 
situations prompted the authors to develop a simple and 
rapid PCR-RPLP assay for detecting borrelial DNA from 
skin biopsy samples and for directly identifying the 
causative species. 
Various PCR primer sets have been devised to amplify 
DNA of Lyme disease borreliae.31-39 Most of the primers 
were designed to be specific to the OspA or flagellin 
gene and have been used for clinical diagnosis. In the 
OspA gene-targeted PCR analysis,31z40 not all strains of 
Lyme disease borreliae could be amplified, because the 
differences in the OspA gene sequence of B. burgdorferi 
sensu stricto, B. garinii, and B. afzelii are pronounced.13,‘* 
To overcome this defect, several species-specific primer 
sets have been designed.’ However, the reactivities of 
those primer sets against other Borrelia species related 
to Lyme disease borreliae are unknown. On the other 
hand, the flagellin gene-targeted PCR can amplify borre- 
lial DNA irrespective of differences in various geographic 
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strains,40,41 because the flagellin gene is highly conserved 
among Lyme disease borreliae and their relatives.13J”,38 
Nevertheless, as shown in a previous report,16 minor dif- 
ferences in the flagellin genes can be used to differenti- 
ate Borrelia species. 
The density of borrelial cells in cutaneous and inter- 
nal lesions is unknown; however, it seems to be low, 
because few borreliae were found in histopathologic 
specimens. 42 To amplify borrelial DNA from tissues and 
body fluids, several researchers used a single primer set 
in their early PCR systems, and the sensitivity and speci- 
ficity were intensified by hybridization, using probes 
complementary to amplicons. 32,33,39,43,44 Recently, nested 
PCR has frequently been used as a highly sensitive test 
for the diagnosis of Lyme disease.35,36,45-47 This method 
has the advantage that amplified borrelial DNA is easily 
discernible in ethidium bromide-stained agarose gels 
without intensifying the signals by hybridization. There- 
fore, in this study, this method was applied for amplify- 
ing the partial flagellin genes from tissue samples and its 
specificity was evaluated by analyzing the RFLP of the 
amplicons. 
The nested PCR system was consistent, reproducible, 
and unaffected by vast excesses of host DNA. With regard 
to sensitivity, the authors estimated that the density of 
10 to 10’ borrelial cells per 10 mg cutaneous tissue was 
the lower limit for detecting infections. Therefore, a false- 
negative result may occur in this system if the number of 
borreliae present in the minute tissue sample is decreas- 
ing to a level of 1 to 10. The chromosome copy number 
per borrelial cell may also have influence on the sensi- 
tivity of this detection system. The number has not yet 
been reported for Lyme disease borreliae, but an investi- 
gation with the relapsing fever agent, Borrelia hermsii, 
revealed a relatively high value of 16 chromosome copies 
per cell for borreliae grown in mice.48 
Earlobe and heart tissues of mice experimentally 
infected with B. burgdorferi sensu stricto, B. garinii, or 
B. afzelii were used to evaluate the sensitivity and speci- 
ficity of the PCR system. Positive PCR results were 
obtained from all tissue samples irrespective of differ- 
ences in the causative species. The PCR for murine tissues 
was slightly more sensitive than culture in detecting the 
presence of borreliae. Each RFLP pattern of PCR prod- 
ucts completely corresponded to the causative species, 
indicating that the amplicons originated from borreliae 
present in the tissues. The diagnostic value of PCR has fre- 
quently been assessed by using animal models.33,44-46 In 
most animal studies reported to date, borrelial infection 
was induced by needle inoculation of cultured cells; how- 
ever, this infection does not accurately reflect the natural 
infection. Therefore, in this experiment, the authors 
included mice naturally infected with B. garinii by tick 
bites. Even in those mice, positive PCR signals were 
obtained. 
The fate of borrelial DNA after antibiotic treatment 
was also examined in earlobe and heart tissues of mice 
infected with B. garinii by tick bites. As reported by 
Malawista et aLd9 the ability to amplify borrelial DNA 
quickly disappeared from tissues that had become cul- 
ture-negative after antibiotic treatment. Although the in 
vivo kinetics for the clearance of dead borrelial cells is 
unknown, PCR amplification probably occurs if suffi- 
cient numbers of viable borrelial cells are present in tis- 
sue samples. 
In clinical application of the nested PCR-RPLP sys- 
tem, the authors obtained satisfactory results concerning 
the sensitivity and specificity. Results of both PCR and 
culture tests were negative in all samples of erythematous 
lesions that were considered to be hypersensitivity reac- 
tions induced by tick bites. In lesions clinically diagnosed 
as erythema migrans, both PCR and culture tests fre- 
quently yielded positive results. All PCR-positive speci- 
mens also were positive by culture, and the causative 
species could be identified as B. garinii by analyzing the 
RPLP of tissue-derived amplicons. The apparent false-neg- 
ative result by PCR occurred in a sample from patient 
15, which showed a positive result by culture. This dis- 
crepancy may be due to the low density or inconsistent 
distribution of borreliae in the cutaneous samples. 
Histopathologic studies on Lyme disease demonstrated 
that distribution of borreliae was not uniform, but rather 
occurred in a multifocal pattern.43J0 Interestingly, in 
patient 10, with typical erythema migrans, the fla type 
determined in the peripheral reddish lesion was different 
from that in the central non-reddish lesion. This case 
seems to have been infected with two different types of 
borreliae by the bite of a co-infected tick. Simultaneous 
infection of different Borrelia species in human Lyme 
disease has been reported in Europe.’ Clearance of bor- 
relial DNA in human cutaneous tissues following antibi- 
otic treatment could be examined in patient 2. This case 
was treated with intravenous injection of ceftriaxone (2 
g/d) for 10 days, and a biopsy sample was retaken from 
the initial biopsy site 18 days after therapy. Both PCR and 
culture tests for this sample yielded negative results, sug- 
gesting that the PCR analysis is applicable to evaluate the 
efficacy of antibiotic treatment. 
CONCLUSION 
The nested PCR-RFLP system could be used as an easy and 
reliable diagnostic tool for the detection and species iden- 
tification of borreliae in human cutaneous biopsies. In this 
system, it took 2 days to complete the analysis. This rapid- 
ity is important for planning the antibiotic treatment in 
the early phase of infection. Because the devised primers 
are complementary to the conserved regions of the fla- 
gellin genes, this system may have universal application 
for clinical and epidemiologic uses in various localities of 
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the world. In the present stuCty the usefulness of this nested 
PCR-RFLP system for other Borrelia species (B.japonica, 
B. tanukii, B. turdae, and B. andersonni and the genomic 
groups PotiB2, VSlI6, and DN127) could not be deter- 
mined; however, this system may apply to these species. 
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